Form 4 for VRDN Viridian Therapeutics, Inc.\DE
Accepted 2026-08-20 20:05:06 ET · period of report 2026-08-19 · accession 0001193125-26-359636 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-20 20:05 | 2026-08-19 | VRDN | Tousignant Jennifer | CLO | S - Sale+OE | $24.50 | -14.2K | 0 | -100% | -$348.2K |
| D | 2026-08-20 20:05 | 2026-08-19 | VRDN | Tousignant Jennifer | CLO | M - OptEx | $14.41 | +10.0K | 10.0K | New | +$144.1K |
| D | 2026-08-20 20:05 | 2026-08-19 | VRDN | Tousignant Jennifer | CLO | M - OptEx | $0.00 | -10.0K | 114.1K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-19 | S | D | 4,212 | $24.50 | 0 | D | — | — | (F1) The shares sold include 718 shares previously acquired by the reporting person pursuant to the Viridian Therapeutics, Inc. Employee Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c). |
| 2 | Common | Common Stock | 2026-08-19 | M | A | 10,000 | $14.41 | 10,000 | D | — | — | |
| 3 | Common | Common Stock | 2026-08-19 | S | D | 10,000 | $24.50 | 0 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-08-19 | M | D | 10,000 | $0.00 | 114,072 | D | $14.41 · — to 2035-03-03 | 10,000 Common Stock | (F2) The option was granted on March 3, 2025 and vests in 48 equal monthly installments following the date of the grant, subject to the Reporting Person's continued service to Issuer through each vesting date. |